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Collagen implants equipped with ‘fish scale’-like 
nanoreservoirs of growth factors for bone 
regeneration
Bone has a capacity to regenerate after suffer-
ing partial damage. However, this regeneration 
becomes difficult when a serious break or tumor 
lesion occurs and the loss of tissue is substantial. 
Today, these cases are treated with various grafts 
with a number of disadvantages, such as limita-
tions with donors. There is a demonstrated clini-
cal need for alternatives of autologous fresh bone 
graft with excellent biological performance. 
Smart nanoengineered materials allow novel 
therapeutic modalities such as improved specific 
cell targeting by means of  nanoparticle-based 
drugs, resulting in a decreased side effects for 
patients. Recently, nanomedicine has taken issue 
for drug delivery, gene delivery and regenerative 
medicine [1–4]. Other advances are being made in 
sophisticated biomaterials for use in less invasive 
surgical implantations, leading to shorter recov-
ery times and decreased risk of postoperative 
infections or other complications. Such innova-
tions will improve the quality of life, extend life 
expectancies and should reduce the overall cost 
of healthcare.
Biomaterials also play central roles in mod-
ern strategies in regenerative medicine and 
tissue engineering as designable biophysical 
and biochemical milieus that direct cellular 
behavior and function. Tissue engineering is 
an inter disciplinary field that has attempted to 
implement a variety of processing methods for 
synthetic and natural polymers to fabricate tissue 
and organ regeneration scaffolds. Such materials 
should provide provisional 3D supports to inter-
act with cells in ways that control their function 
by guiding the spatially and temporally complex 
multicellular processes of tissue formation and 
regeneration [5–12]. The guidance provided by 
biomaterials may facilitate restoration of struc-
ture and function of damaged or dysfunctional 
tissues. 
Several biomimicking medical devices for 
regenerative medicine have been inspired by 
the intricate fibrillar architecture of natural 
extracellular matrix (ECM) components [13]. 
Such matrices have already shown remarkable 
success in tissue-engineering applications [8,14], 
examples of which include reconstruction of a 
dog urinary bladder [13] and the regeneration 
after brain injury in a mouse stroke model [15]. 
However, it has been established that inert ECM 
mimetic scaffolds are not efficient at generating 
durable tissue repair. Therefore, there is a need 
for materials that ensure the sustained release of 
active compounds. To this end, recent advances 
in nanotechnology have led to various engi-
neered ECM analogs and biomaterials incor-
porated with active compounds (drugs, genes or 
growth factors) within the form of layer-by-layer 
(LbL) coatings built-up from oppositely charged 
macromolecules [16–32].
As considerable effort is currently devoted to 
the design of nanostructured functional materi-
als, ultrathin polyelectrolyte multilayer (PEM) 
coatings built-up from oppositely charged mac-
romolecules constitute promising candidates, 
particularly in the field of biomaterials [16,17,31,33]. 
These supramolecular nanoarchitectures can 
not only specifically control cell activation, but 
Implants triggering rapid, robust and durable tissue regeneration are needed to shorten recovery times 
and decrease risks of postoperative complications for patients. Here, we describe active living collagen 
implants with highly promising bone regenerative properties. Bioactivity of the implants is obtained 
through the protective and stabilizing layer-by-layer immobilization of a protein growth factor in association 
with a polysaccharide (chitosan), within the form of nanocontainers decorating the collagen nanofibers. 
All components of the implants are US FDA approved. From both in vitro and in vivo evaluations, the 
sophisticated strategy described here should enhance, at a reduced cost, the safety and efficacy of the 
therapeutic implants in terms of large bone defects repair compared with current simplistic approaches 
based on the soaking of the implants with protein growth factor.
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also mediate the local delivery of drugs, pep-
tides, proteins or DNA, previously grafted, 
adsorbed or embedded into the multilayered 
films [19,21–27,30,33].
In orthopaedic surgery, Geistlich Bio-Gide™ 
collagen membranes are currently used for 
guided bone regeneration and guided tissue 
regeneration. The success of this membrane is 
based on the natural bilayer structure, which 
contributes to excellent soft-tissue integration 
and optimal bone regeneration [34–36]. The 
objective of this study was to implement the 
multilayered nanostructures approach to equip 
those already used in the clinic devices with 
nanocontainers of active compounds capable of 
improving the rate of bone regeneration: chito-
san (CHI), a biocompatible polysaccharide with 
bone regenerative properties [37,38]; and BMP-2, 
a growth factor known to accelerate ECM pro-
duction and bone tissue integration [39]. First, we 
inspected the build-up of our coating with quartz 
crystal microbalance with dissipation monitor-
ing (QCM-D) and the structure and topography 
of our nanofibers by scanning electron micros-
copy (SEM). The potency of the BMP-2-loaded 
scaffolds with regards to bone regeneration was 
assessed both in vitro and in vivo.
Methods
n Materials
CHI was purchased from Sigma (France) and 
Protasan up CL 113 was from FMC Biopolymer 
(Norway). DGL adendri-graft poly-l-lysine was 
purchased from Colcom (Montpellier, France). 
In this study, we used the fifth-generation 
DGLG5. Human recombinant BMP-2 was pur-
chased from PeproTech (France). Bio-Gide col-
lagen membranes was purchased from Proforma 
(Geistlich Bio-Gide 30 × 40 mm).
n Quartz crystal microbalance with 
dissipation monitoring
QCM-D was operated with a D300 system 
(Q-Sense, Sweden) using a QAFC302 f low 
chamber and QSX301 gold-coated quartz crys-
tal sensors. This technique consists of measuring 
the resonance frequency shifts (∆f ) and the dis-
sipation factor changes (∆D) of the quartz crys-
tal sensor upon material deposition. The LbL 
build-up was performed by successive injections 
of polyelectrolyte or protein solutions (500 µl) 
and rinsing solution (500 µl) through the flow 
chamber and was monitored in situ. Changes 
in the resonance frequencies were measured 
at the third overtone (n = 3) corresponding to 
the 15-MHz resonance frequency. A shift in 
∆f can be associated, in the first approxima-
tion, to a variation of the mass adsorbed onto 
the crystal through the Sauerbrey relationship: 
m = − C × ∆ f/ n. Where C is a constant charac-
teristic of the crystal used (C = 17.7 ng cm-2 Hz-1). 
CHI (500 µg ml-1) and BMP-2 (200 ng ml-1) 
were adsorbed by using 0.04 M MES (pH: 5.5) 
and 0.15 M NaCl solutions.
n Build-up of the LbL films onto 
collagen membrane
For all biological activity experiments, 
(CHI/BMP-2)
6
 nanoarchitectures were built-
up onto Bio-Gide scaffolds by the LbL method 
by alternating immersions during the 15 min in 
the adequate solutions (300 µl) at the respec-
tive concentrations of 500 µg ml-1 for CHI 
and DGLG5 solutions and 200 ng ml-1 for the 
BMP-2 solutions in presence of 0.04 M MES 
and 0.15 M NaCl at pH 5.5. After each deposi-
tion step, the membranes were rinsed for 15 min 
with 0.04 M MES and 0.15 M NaCl at pH 5.5. 
All membranes were sterilized for 30 min by 
exposure to UV light (254 nm; 30 W; distance 
20 cm), and equilibrated in contact with 1 ml of 
serum-free medium prior to cell culture.
n SEM observation
For morphological study, the scaffolds were gold-
coated (Edwards Sputter Coater®, Edwards, 
Genevilliers, France) and observed with a Phil-
ips XL-30 ESEM® (Polymex, Fuveau, France) 
scanning electron microscope in conventional 
mode (high vacuum) with a Thornley-Everhart® 
(Polymex) secondary electron detector.
n Cell culture
Human primary osteoblasts (HOB) were 
obtained from Cell Applications and cul-
tured in Dulbecco’s modified Eagle’s medium 
(D-MEM®, Life Technologies, Saint Aubin, 
France) containing 50 U ml-1 penicillin, 50 µg 
ml-1 streptomycin, 2.5 µg ml-1 amphotericin B 
and 10% FBS (Life Technologies, Paisley, UK). 
The cells were incubated at 37°C in a humidi-
fied atmosphere of 5% CO
2
. When cells reached 
subconfluence, they were harvested with trypsin 
and subcultured.
n In vitro cell viability & proliferation
Cell viability was determined by trypan blue 
exclusion. AlamarBlue® (Serotec, France) was 
used to assess cellular proliferation. The Ala-
marBlue test is a nontoxic, water-soluble, colo-
rimetric redox indicator that changes color 
in response to cell metabolism. In this study, 
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2 × 104 human osteoblasts were seeded on top of 
LbL-coated 14-mm-diameter scaffolds (n = 3) 
placed on 24-well plates. After 2 days of cul-
ture, cells were incubated in 10% AlamarBlue/
DMEM solution in a humidified atmosphere at 
37°C and 5% CO
2
. After 4 h, 100 µl of incu-
bation media was transferred to 96 well plates 
and measured at 590 nm and 630 nm in order 
to determine the percentage of AlamarBlue 
reduction.
n In vitro analysis of the 
mineralization using a fluorescent dye
Xylenol orange powder (Sigma) was dissolved in 
distilled water to make the 20 mM stock solu-
tion. Xylenol orange was added to medium over-
night to a final concentration of 20 µM. Before 
the microscopic examination, the samples were 
rinsed with fresh medium without fluorochrome 
to avoid nonspecific fluorescence. Xylenol orange 
expresses a red color under the f luorescent 
 microscope (LEICA DM4000 B).
n Immunofluorescence
Collagen scaffolds with and without BMP-2 
were seeded with 2 × 104 HOB cells. After 
21 days of culture in proliferation medium, cells 
were fixed with 4% PFA for 1 h, rinsed three 
times with PBS, permeabilized with 0.1% Tri-
ton X-100 for 1 h, then rinsed three times with 
PBS. Indirect immunostaining was performed 
after the fixation. The primary antibody used 
was the rabbit polyclonal antioteopontin (1/600, 
Abcam, Paris, France) incubated for 20 min for 
bone detection. The secondary antibody was 
goat antirabbit conjugated to Alexa Fluor 488 
(1/250, Invitrogen Molecular Probes, Eugene, 
USA) incubated overnight. After three rinses 
with PBS, cells were mounted on microscope 
slides using Vectashield (Vector Laboratories, 
Peterborough, UK) and imaged by a microscope 
equipped for fluorescence (LEICA DM4000B).
n In vitro analysis of the 
mineralization using Alizarin Red S 
staining
The samples were fixed with a solution of PFA 
4% in PBS overnight at 4°C. They were then 
dehydrated through a series of increasing ethanol 
concentrations, cleared with toluene and embed-
ded in paraffin wax. Sections were cut at 7 µm 
using a sledge microtome and mounted on glass 
slides. After the removal of paraffin wax, sec-
tions of the different samples were stained using 
Alizarin Red S (Sigma Aldrich). Alizarin Red 
S powder was dissolved in distilled water in a 
concentration of 2 g per 100 ml. The samples 
were incubated in the Alizarin Red solution for 
20 min and then rinsed with distilled water sev-
eral times. The sections were then observed under 
the optical microscope (LEICA DM4000 B).
n In vivo implantations
In this study, nude mice were implanted on the 
skull. The mice were anesthetized with isoflu-
orane gas and animals were placed on ventral 
decubitus on a heating table, with strict aseptic 
conditions after skin incision, two bony defects 
(5-mm size of bony defect) were performed using 
an electric drill with a sterile round bur under 
irrigation of sterile normal saline before deposi-
tion of two samples and sutures with Ethicon 
9/0. The skin was closed with sutures and the 
animal’s behavior was observed after waking up. 
The mice were sacrificed with an intraperitoneal 
injection of a lethal dose of ketamine and the 
samples are extracted after 42 days of implanta-
tion. For all in vivo studies, male MF1-nu/nu 
Figure 1. Macroscopic views of the Geistlich Bio-Gide™ collagen 
membranes currently used, in the clinic for bone regeneration. Scale 
bars: 2.5 mm.
Figure 2. scanning electron microscopy visualization of the Bio-Gide™ 
collagen nanofibers. (A) Before treatment (native, not functionalized), and 
(B) after deposition of a (chitosan/BMP-2)
6
 architecture (functionalized). Scale bars: 
1 µm.
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mice (5 weeks old, weight 30 g) were purchased 
from Harlan (IL, USA) and acclimatized for 
a minimum of 1 week prior to experimenta-
tion. All procedures were performed with prior 
received ethical approval and carried out in 
accordance with the regulations laid down for 
animals.
n Histological examination of bone 
regeneration using Mallory coloration
The implants were fixed with BouinHollande 
solution for 2 days. Then, they were dehydrated 
through a series of increasing ethanol concen-
trations, cleared with toluene and embedded in 
paraffin wax. Sections were cut at 7 µm using a 
sledge microtome and mounted on glass slides. 
After the removal of paraffin wax, the sections 
were stained using Mallory coloration for 2 days.
n Confocal Raman microspectroscopy
After 42-day implantation into mouse calvaria, 
the implants were explanted, rinsed with PBS, 
fixed with PFA 4% for 24 h at 4°C, then rinsed 
three times and stored in PBS. Prior to Raman 
analysis, the implants were briefly rinsed with 
water and dried under a gentle flow of argon. 
Raman measurements were carried out in air 
using a confocal Raman microspectrometer com-
posed of a Raman spectrometer (LabRam HR® 
[Horiba Scientific, Neuhausen, Germany] by 
Jobin-Yvon Horiba with a 600 line mm-1 grating) 
coupled to a microscope (Model BX41, Olym-
pus, France) with xyz mapping stage via optical 
fibers. The excitation of Raman scattering was 
operated with a helium-neon laser at a wave-
length of 632.8 nm. The laser beam was focused 
on the sample by means of a ×50LWD micro-
scope objective. Confocal pinholes of 400 µm 
diameter for single spectra and 250-µm diameter 
for 2D mappings placed before the entrance slit 
were used to reject Raman signal from out-of-
focus planes. Raman spectra with a good signal-
to-noise ratio were recorded with an integration 
time of 60 s for single spectra and 20 s for 2D 
mappings.
results & discussion
Recently, we have reported on the effective 
incorporation of BMP-2 into (DGLG5/BMP-2)
6
 
LbL architectures with DGL, a dendrigraft of 
poly-l-lysine [39]. The mean amount of hydrated 
BMP-2 growth factor immobilized was approx-
imately 1.53 µg cm-2. Here, we have used US 
FDA-approved CHI as polycationic polysac-
charide to incorporate the BMP-2 into the 
nanostructured coatings. CHI is derived from 
chitin, a poly saccharide found in the exoskel-
eton of shellfish such as shrimps, lobsters and/or 
crabs. The effective build-up of (CHI/BMP-2)
n
 LbL architectures onto gold-coated substrates 
was demonstrated by QCM-D up to six adsorp-
tion cycles. It followed a linear growth regimen 
with deposited mass increments of approximately 
1.1 µg cm-2 corresponding to 10 nm in equiva-
lent uniform thickness upon each new deposited 
CHI/BMP-2 layer pair. The mean amount of 
hydrated BMP-2 growth factor immobilized was 
approximately 0.73 µg cm-2, which is twofold 
lower than with DGLG5. This must be due to 
more efficient interactions of the protein with 
the dendritic structure of DGLG5 than with the 
linear structure of CHI. Our ultimate goal is to 
propose this new implant as a unique active med-
ical device, we have chosen the FDA-approved 
CHI and not DGL. After SEM analysis of the 
Figure 4. Calcium deposit analysis. Xylenol orange detection (in red) of calcium 
deposit on the collagen nanofibers after 21-day incubation of human osteoblasts 
(A) before and (B) after functionalization with (chitosan/BMP-2)
6
 nanocontainers. 
Intensity average quantification: (A) 22.5 ± 2.3 and (B) 51.2 ± 4.1. We have an 
increase of 23% of bone mineralization by using the functionalized implant in the 
presence of chitosan/BMP-2 compared with the native implant. Scale bars: 50 µm.
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Figure 3. In vitro proliferation of human osteoblasts growing onto the 
native collagen nanofibers and onto the collagen nanofibers functionalized 
by (chitosan/BMP-2)6 nanoreservoirs (functionalized) after 3, 7, 14 and 
21 days.  
F: Functionalized by chitosan/BMP-2; NF: Not functionalized (native).
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nanofiber collagen implant before and after the 
coating, we have preferred to functionalize the 
implants by (CHI-BMP-2)
6
 and not (CHI-
BMP-2)
3
, showing more homogeneity of the 
coating. 
The aim of this work is to functionalize 
active collagen membrane by active nanocon-
tainers that are able to increase the speed of 
bone regeneration. The effective deposition, 
and nanoscale dimensions, of the bioactive 
coating onto Bio-Gide collagen membranes 
(Figure 1) were confirmed by means of SEM. 
While the native nanofibers displayed a smooth 
topography (Figure 2A), (CHI/BMP-2)
6
-treated 
nanofibers were coated with uniformly distrib-
uted ‘fish scale’-like nanostructured deposits 
(Figure 2B). Interestingly, this open fish scale-like 
morpho logy was very different from the com-
pact spheroid morphology of (DGLG5/BMP-2)
6
 
deposits obtained both on collagen membranes 
and on poly-e-caprolactone (PCL) membranes 
[39]. Distinct morphologies can be explained 
by the low flexibility/high persistence length 
(6–12 nm) of CHI chains [40], limiting the 
interactions with BMP-2, while the high flex-
ibility/low persistence length (2 nm) of poly-l-
lysine chains of DGL allows optimized interac-
tions with BMP-2 [41].
In order to explore the capacity of the modi-
fied collagen membranes to induce bone for-
mation in vitro, we have first compared the 
adhesion of human osteoblasts onto native or 
(CHI/BMP-2)
6
-treated collagen implants. In 
line with recently published data [42,43], mor-
phology changes between cells adhering onto 
native and LbL-treated collagen scaffolds were 
likely to be due to the combined modifications of 
both the surface chemistry and the nanotopog-
raphy upon the LbL treatment (data not shown).
We then followed the proliferation and cell 
activity of human osteoblasts for 21 days onto 
(CHI/BMP-2)
6
-treated collagen implants com-
pared with native implants (Figure 3). Our results 
showed similar cell behavior for both the func-
tionalized and not collagen membranes (Figure 3), 
reaching a peak value at day 14. Cell activity 
then significantly decreased between day 14 and 
day 21 for both types of substrate. This fall down 
in proliferation and cell activity, at this stage, 
is certainly due to the osteoblasts undergoing 
differentiation to produce their own biomin-
eralized ECM. We have also shown that after 
21 days of culture, the proliferation decreased 
dramatically due to the mineralization at this 
stage (Figure 4). Therefore, at 42 days we are 
unable to follow the proliferation. These results 
show that the functionalization of the collagen 
implants with (CHI/BMP-2)
6
 nanocontainers 
did not impair the cell activity.
In order to assess the improvement of 
in vitro bone formation induced by primary 
osteoblasts in contact with the BMP-2 nano-
containers, we compared the extent of calcium 
depositions onto the native collagen implant 
and (CHI/BMP-2)
6
-treated membranes in 
the presence of primary osteoblasts. In this 
study, Xylenol orange f luorescence used as 
staining for the specific calcium depositions 
clearly indicated more mineralization onto 
(CHI/BMP-2)
6
-treated collagen scaffolds than 
onto the native scaffold (Figure 4). After an inten-
sity average quantification (22.5 ± 2.3  (Figure 4A) 
and 51.2 ± 4.1 (Figure 4B)), we have shown an 
increase of 23% of bone mineralization by 
using the functionalized implant (CHI/BMP-2) 
compared with the native implant. We have 
also analyzed by immunochemistry the capac-
ity of these nanoreservoirs, in the presence of 
human osteoblasts, to induce in vitro-specific 
Figure 5. osteopontin expression (in green) in primary osteoblasts cells 
cultured for 21 days on (A) nonfunctionalized collagen membrane and (B) 
functionalized (chitosan/BMP-2)6-treated collagen membrane. No 
osteopontin induction was detected by using (chitosan/BSA)
6
-treated collagen 
membrane as a negative control. Scale bars: 20 µm.
Figure 6. Alazarin red detection of bone mineralization. Alizarin Red 
detection of calcium depositions on the collagen nanofibers after 21-days 
incubation of human osteoblasts (A) before and (B) after functionalization with 
(chitosan/BMP-2)
6
 nanocontainers. No calcium deposition was detected after 
21 days of culture on the native collagen membrane without BMP-2. Scale bars: 
100 µm.
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osteopontin expression after 21 days of culture 
(Figure 5). This result strongly suggests that the 
entrapment of BMP-2 into fish scale-like CHI-
based LbL nanocontainers preserved its acces-
sibility to osteoblast cells, as well as its ability 
to increase and accelerate the mineralization of 
the ECM produced by the osteoblasts. For more 
in vitro analysis, we have also followed by Aliza-
rin Red detection the calcium deposition on the 
collagen nanofibers after 21 days incubation of 
human osteoblasts before and after functional-
ization with (CHI/BMP-2)
6
 nanoreservoirs, and 
shown calcium deposition when functionalized 
by BMP-2 (orange detection) and no deposition 
on the native collagen implant (Figure 6).
After the in vitro bone induction, we also 
analyzed the potential of our active implants 
to induce bone regeneration in vivo. A native 
collagen implant and a (CHI/BMP-2)
6
-treated 
implant were implanted into mouse calvaria 
defects for 42 days. The histological study was 
then carried out to observe the scaffold coloni-
zation by the host cells in the bone defect site, 
the osseointegration and the new bone miner-
alization. Mallory coloration was used in order 
to distinguish between mineralized bone, ECM 
and nuclear cell (Figure 7). The results clearly 
indicate excellent osseointegration of both 
(CHI/BMP-2)
6
-treated and untreated collagen 
membranes, with slightly better results for the 
treated implant (Figure 7B). Colonization and 
migration of osteoblasts from the site of implan-
tation within both implants clearly occurred, as 
shown by the fibrous aspect of the samples filled 
with native osteoblasts. However, the (CHI/
BMP-2)
6
-treated collagen implant appears to 
be more cohesive and shows the formation of 
an ECM undergoing  mineralization (Figure 7B).
The bone mineralization of a native col-
lagen implant, and a (CHI/BMP-2)
6
-treated 
collagen implant after 42-day implantation in 
calvaria was also inspected by confocal Raman 
microspectroscopy, to detect calcium phos-
phate (CaP) deposition (Figure 8). In this study, 
we have also analyzed, as a control, a treated 
implant by using a dendrigraft of l-lysine 
(DGLG5) instead of CHI. These implants were 
also implanted and analyzed in order to test the 
versatility of the LbL method for embedding 
BMP-2 onto the collagen proposed new device. 
The Raman signatures were very similar for all 
the implanted scaffolds, except for the bands 
at 430–450 cm-1 (n
2
 PO
4
3-), 580–610 cm-1 
(n
4
 PO
4
3-), 962 cm-1 (n
1
 PO
4
3-) and 1072 cm-1 
(n
1
 CO
3
2- and n
3
 PO
4
3-), which, promisingly, are 
relative to B-type carbonated hydroxyapatite 
(PO
4
3- substituted by CO
3
2), the major mineral 
component of bone (Figure 8) [44,45]. 2D map-
pings of the 962-cm-1 Raman peak intensity 
of B-type carbonated hydroxyapatite revealed 
extensive in vivo mineralization over both 
(CHI/BMP-2)
6
- and (DGLG5/BMP-2)
6
-treated 
scaffolds, while no trace of mineralization was 
found atop the untreated implant after 42 days 
implantation (Figure 8). These results support the 
promising effect of BMP-2-based nanocon-
tainer deposits on the biomineralization of the 
implants. In line with our previous work with 
PCL nanofibrous implants [39], DGLG5-based 
nanoreservoirs of BMP-2 was confirmed here 
to be a versatile and efficient strategy to induce 
bone formation. CHI-based nano reservoirs of 
BMP-2 show similar results in terms of biomin-
eralization in vivo, and seem, to us, to be more 
promising in the short-/mid-term because CHI 
is an FDA-approved component, while DGLG5 
is not yet. In addition, although DGLG5 was 
shown to allow higher loading of the nanores-
ervoirs with BMP-2 than CHI, as seen before, 
the amount of growth factor immobilized by 
means of CHI is sufficient to reach the same 
extent of implant biomineralization. This can 
be due to the open fish scale-like morphology 
of CHI-based nanoreservoirs allowing easier 
degradation, and thus offering better acces-
sibility to BMP-2 to the cells than the com-
pact spheroid morphology of DGLG5-based 
nanoreservoirs [39].
Conclusion
At this stage, our results show that we can func-
tionalize a collagen implant already used in the 
clinic with nanocontainers of BMP-2 made by 
CHI (FDA approved), induce bone formation 
in vitro and in vivo, and accelerate the speed of 
bone regeneration in vivo.
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Figure 7. Histological analysis of bone induction. Histological analysis and the 
detection of bone induction after 42 days in vivo implantation on skull of nude 
mice of the (A) native collagen implant and the (B) functionalized collagen implant 
by the active nanoreservoirs of (chitosan/BMP-2)
6
. Blue areas show cell 
colonization. Scale bars: 25 µm. 
*: Host bone (orange/red); #: New mineralized matrix (yellow); M: Collagen 
membrane nanofibers;. 
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The European and American authorities 
have already approved the use of BMP-2 for 
bone regeneration applications. For example, 
Medtronic offers InductOS™ (Medtronic, 
Boulogne-Billancourt, France), which is a 
basic collagen matrix soaked in BMP-2. The 
efficacy of this kind of combination device is 
dependent on slow release kinetics for BMPs, 
which is recognized as the critical, most chal-
lenging requirement for combination implants. 
For efficient bone regeneration, the target cells 
require a reliable and continuous exposure 
to growth factors over an extended period of 
time, until the induction of new bone. How-
ever, degradation of BMP-2 occurs rapidly in 
aqueous solution. With current systems using 
collagen matrices soaked with the growth factor, 
this problem is addressed by overdosing, which 
may induce adverse side effects. The novelty 
of our approach lies in the nanoimmobiliza-
tion of BMP-2. The nano structured scaffold is 
produced by the LbL technology, which allows 
to be entrapped the growth factor into nano-
containers atop the scaffold fibers. Recently, 
we have elucidated the mechanism by which 
cells come in to contact and interact with such 
nanostructured coating [19,43]. Encapsulated by 
polymers, BMP-2 is likely to be protected and 
stabilized. Once cells come into contact with 
the deposits, cellular enzymes degrade this poly-
mer coating and BMP-2 becomes available. As 
cells grow, divide and infiltrate deeper into the 
porous structure of the membrane, they provoke 
a slow and progressive release of BMP-2 that, in 
turn, further stimulates the biomineralization of 
the ECM. This strategy aims to considerabley 
enhance therapeutic efficacy and should lead to 
implants that are capable, at a reduced cost, of 
more robust and durable bone repair in large 
defects compared with current less sophisticated 
approaches.
Future perspective
Over the next decades, new therapeutics based 
on nanotechnology could offer significant oppor-
tunities to revolutionize medicine. On the other 
hand, if nanomedicine wants to realize its full 
potential, some major legal and economic obsta-
cles have to be removed. Here, we describe active 
living collagen implants with highly promising 
bone regenerative properties. Our nanotechnol-
ogy approach allows protective encapsulation as 
a nano ‘fish scales’ like of active growth factor. 
This strategy may be used as a new design reflec-
tion for a future generation of smart implants for 
regenerative nanomedicine application.
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Figure 8. raman analysis of native 
(chitosan/BMP-2)6-treated and 
(dGLG5/BMP-2)6-treated collagen implants 
after 42-day implantation in mouse 
calvaria. (A) Typical Raman spectra showing 
the biomineralization of calcium phosphate 
within the form of carbonated hydroxyapatite 
over both BMP-2-enriched implants, and not 
over the native implant. Spectra were offset for 
the sake of clarity. (B & C) 2D mapping of the 
962 cm-1 Raman peak of carbonated 
hydroxyapatite over the BMP-2-enriched 
implant (100 × 100 µm2; mesh size 2.8 µm).
Collagen implants equipped by ‘fish scale’-like nanoreservoirs for bone regeneration ReseaRch aRticleReseaRch aRticle Eap, Ferrand, Schiavi et al.
 
 
 
 
 
 
 
A
tho
r P
ro
of 
Nanomedicine (2012) x(x)doi:10.2217/NNM.13.122 future science group
references
1 Farokhzad OC, Langer R. Nanomedicine: 
developing smarter therapeutic and diagnostic 
modalities. Adv. Drug Deliv. Rev. 58(14), 
1456–1459 (2006).
2 Liu Y, Miyoshi H, Nakamura M. 
Nanomedicine for drug delivery and imaging: 
a promising avenue for cancer therapy and 
diagnosis using targeted functional 
nanoparticles. Int. J. Cancer 120(12), 
2527–2537 (2007).
3 Caruthers SD, Wickline SA, Lanza GM. 
Nanotechnological applications in medicine. 
Curr. Opin. Biotechnol. 18(1), 26–30 (2007).
4 Wagner V, Dullaart A, Bock AK, Zweck A. 
The emerging nanomedicine landscape. 
Nat. Biotechnol. 24(10), 1211–1217 (2006).
5 Peppas NA, Langer R. New challenges in 
biomaterials. Science 263(5154), 1715–1720 
(1994).
6 Hubbell JA. Biomaterials in tissue 
engineering. Biotechnology (NY) 13(6), 
565–576 (1995).
7 Langer R, Tirrell DA. Designing materials for 
biology and medicine. Nature 428(6982), 
487–492 (2004).
8 Griffith LG, Naughton G. Tissue engineering 
– current challenges and expanding 
opportunities. Science 295(5557), 1009–1014 
(2002).
9 Chaikof EL, Matthew H, Kohn J, Mikos AG, 
Prestwich GD, Yip CM. Biomaterials and 
scaffolds in reparative medicine. Ann. NY 
Acad. Sci. 961, 96–105 (2002).
10 Yang C, Hillas PJ, Baez JA et al. 
The application of recombinant human 
collagen in tissue engineering. BioDrugs 
18(2), 103–119 (2004).
11 Kumar G, Tison CK, Chatterjee K et al. 
The determination of stem cell fate by 3D 
scaffold structures through the control of cell 
shape. Biomaterials 32(35), 9188–9196 (2011).
12 Pullela SR, Andres C, Chen W, Xu C, Wang 
L, Kotov NA. Permselectivity replication of 
artificial glomerular basement membranes in 
nanoporous collagen multilayers. J. Phys. 
Chem. Lett. 2(16), 2067–2072 (2011).
13 Lee J, Cuddihy MJ, Kotov NA. 
Three-dimensional cell culture matrices: state 
of the art. Tissue Eng. Part B Rev. 14(1), 
61–86 (2008).
14 Dvir T, Timko BP, Kohane DS, Langer R. 
Nanotechnological strategies for engineering 
complex tissues. Nat. Nanotechnol. 6(1), 
13–22 (2010).
15 Park KI, Teng YD, Snyder EY. The injured 
brain interacts reciprocally with neural stem 
cells supported by scaffolds to reconstitute 
lost tissue. Nat. Biotechnol. 20(11), 1111–1117 
(2002).
16 Choi JH, Park YW, Park TH et al. Fuzzy 
nanoassembly of polyelectrolyte and layered 
clay multicomposite toward a reliable gas 
barrier. Langmuir 28(17), 6826–6831 (2012).
17 Wang D, Rogach AL, Caruso F. 
Semiconductor quantum dot-labeled 
microsphere bioconjugates prepared by 
stepwise self-assembly. Nano. Lett. 2(8), 
857–861 (2002).
18 Berth G, Voigt A, Dautzenberg H, Donath E, 
Mohwald H. Polyelectrolyte complexes and 
layer-by-layer capsules from chitosan/chitosan 
sulfate. Biomacromolecules 3(3), 579–590 
(2002).
19 Jessel N, Atalar F, Lavalle P et al. Bioactive 
coatings based on a polyelectrolyte 
multilayer architecture functionalized by 
embedded proteins. Adv. Mater. 15(9), 
692–695 (2003).
20 Hiller J, Mendelsohn JD, Rubner MF. 
Reversibly erasable nanoporous anti-reflection 
coatings from polyelectrolyte multilayers. 
Nat. Mater. 1(1), 59–63 (2002).
21 Benkirane-Jessel N, Schwinte P, Falvey P 
et al. Build-up of polypeptide multilayer 
coatings with anti-inflammatory properties 
based on the embedding of 
piroxicam–cyclodextrin complexes. Adv. 
Funct. Mater.  14(2), 174–182 (2004).
22 Jessel NB, Schwinte P, Donohue R et al. 
Pyridylamino-beta-cyclodextrin as a 
molecular chaperone for lipopolysaccharide 
embedded in a multilayered polyelectrolyte 
architecture. Adv. Funct. Mater. 14(10), 
963–969 (2004).
23 Benkirane-Jessel N, Lavalle P, Hubsch E et al. 
Short-time tuning of the biological activity of 
functionalized polyelectrolyte multilayers. 
Adv. Funct. Mater. 15(4), 648–654 (2005).
24 Gangloff SC, Ladam G, Dupray V et al. 
Biologically active lipid A antagonist 
embedded in a multilayered polyelectrolyte 
architecture. Biomaterials 27(9), 1771–1777 
(2006).
25 Jessel N, Oulad-Abdelghani M, Meyer F et al. 
Multiple and time-scheduled in situ DNA 
delivery mediated by beta-cyclodextrin 
embedded in a polyelectrolyte multilayer. 
Proc. Natl Acad. Sci. USA 103(23), 
8618–8621 (2006).
26 Dierich A, Le Guen E, Messaddeq N et al. 
Bone formation mediated by synergy-acting 
growth factors embedded in a polyelectrolyte 
multilayer film. Advanced Materials 19(5), 
693–697 (2007).
27 Zhang X, Sharma KK, Boeglin M et al. 
Transfection ability and intracellular DNA 
pathway of nanostructured gene-delivery 
systems. Nano Lett. 8(8), 2432–2436 (2008).
28 Facca S, Cortez C, Mendoza-Palomares C 
et al. Active multilayered capsules for in vivo 
bone formation. Proc. Natl Acad. Sci. USA 
107(8), 3406–3411 (2010).
29 Lee J, Kotov NA. Notch ligand presenting 
acellular 3D microenvironments for ex vivo 
human hematopoietic stem-cell culture made 
by layer-by-layer assembly. Small 5(9), 
1008–1013 (2009).
executive summary
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  This strategy may serve as a design reflection for biologically inspired materials technologies.
Financial & competing interests disclosure
This work was supported by the project Nano OSCAR from 
the ‘Agence Nationale de la Recherche, ANR’. N 
Benkirane-Jessel is indebted to CHU de Nancy, Hôpital 
Central, ‘Chirurgie Orthopédique et Traumatologie’ (Con-
trat d’ interface INSERM vers l’ hôpital). G Ladamc thanks 
the ‘Grand Évreux Agglomération’ and the ‘Conseil Général 
de l’Eure’ for partial financial support of La2B. The authors 
have no other relevant affiliations or financial involvement 
with any organization or entity with a financial interest in 
or financial conflict with the subject matter or materials 
discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of 
this manuscript.
Collagen implants equipped by ‘fish scale’-like nanoreservoirs for bone regeneration ReseaRch aRticleReseaRch aRticle Eap, Ferrand, Schiavi et al.
 
 
 
 
 
 
Au
t o
r P
ro
f 
www.futuremedicine.com doi:10.2217/NNM.13.122 future science group
30 Shim BS, Podsiadlo P, Lilly DG et al. 
Nanostructured thin films made by dewetting 
method of layer-by-layer assembly. Nano Lett. 
7(11), 3266–3273 (2007).
31 Macdonald M, Rodriguez NM, Smith R, 
Hammond PT. Release of a model protein 
from biodegradable self assembled films for 
surface delivery applications. J. Control Release 
131(3), 228–234 (2008).
32 MacDonald Ml, Samuel RE, Shah NJ, Padera 
RF, Beben YM, Hammond PT. Tissue 
integration of growth factor-eluting 
layer-by-layer polyelectrolyte multilayer 
coated implants. Biomaterials 32(5), 
1446–1453 (2011).
33 Shah NJ, Macdonald ML, Beben YM, 
Padera RF, Samuel RE, Hammond PT. 
Tunable dual growth factor delivery from 
polyelectrolyte multilayer films. Biomaterials 
32(26), 6183–6193 (2011).
34 Rothamel D, Schwarz F, Sculean A, Herten 
M, Scherbaum W, Becker J. 
Biocompatibility of various collagen 
membranes in cultures of human PDL 
fibroblasts and human osteoblast-like cells. 
Clin. Oral Implants Res. 15(4), 443–449 
(2004).
35 Zitzmann NU, Naef R, Scharer P. 
Resorbable versus nonresorbable membranes 
in combination with Bio-Oss for guided 
bone regeneration. Int. J. Oral Maxillofac. 
Implants 12(6), 844–852 (1997).
36 Schwarz F, Rothamel D, Herten M et al. 
Immunohistochemical characterization of 
guided bone regeneration at a 
dehiscence-type defect using different barrier 
membranes: an experimental study in dogs. 
Clin. Oral Implants Res. 19(4), 402–415 
(2008).
37 Di Martino A, Sittinger M, Risbud MV. 
Chitosan: a versatile biopolymer for 
orthopaedic tissue-engineering. Biomaterials 
26(30), 5983–5990 (2005).
38 Kim IY, Seo SJ, Moon HS et al. Chitosan and 
its derivatives for tissue engineering 
applications. Biotechnol. Adv. 26(1), 1–21 
(2008).
39 Mendoza-Palomares C, Ferrand A, Facca S 
et al. Smart hybrid materials equipped by 
nanoreservoirs of therapeutics. ACS Nano 
6(1), 483–490 (2012).
40 Cölfen H, Berth G, Dautzenberg H. 
Hydrodynamic studies on chitosans in 
aqueous solution. Carbohydr. Polym. 45(4), 
373–383 (2001).
41 Brant DA, Flory PJ. The configuration of 
random polypeptide chains. I. Experimental 
results. J. Am. Chem. Soc. 87(13), 2788–2791 
(1965).
42 Anselme K, Davidson P, Popa AM, Giazzon 
M, Liley M, Ploux L. The interaction of cells 
and bacteria with surfaces structured at the 
nanometre scale. Acta Biomater. 6(10), 
3824–3846 (2010).
43 Wheeldon I, Farhadi A, Bick AG, Jabbari E, 
Khademhosseini A. Nanoscale tissue 
engineering: spatial control over cell-materials 
interactions. Nanotechnology 22(21), 212001 
(2011).
44 Penel G, Leroy G, Rey C, Bres E. 
MicroRaman spectral study of the PO4 and 
CO3 vibrational modes in synthetic and 
biological apatites. Calcif. Tissue Int. 63(6), 
475–481 (1998).
45 Crane NJ, Popescu V, Morris MD, Steenhuis 
P, Ignelzi MA. Raman spectroscopic evidence 
for octacalcium phosphate and other transient 
mineral species deposited during 
intramembranous mineralization. Bone 39(3), 
434–442 (2006).
Collagen implants equipped by ‘fish scale’-like nanoreservoirs for bone regeneration ReseaRch aRticleReseaRch aRticle Eap, Ferrand, Schiavi et al.
 
 
 
 
 
 
 
Au
tho
r P
ro
of 
